Lake Oswego, Oregon--(Newsfile Corp. - May 18, 2026) - Functional Brands Inc. (NASDAQ: MEHA), a leading innovator in wellness and performance products, today announced financial results for the first quarter ended March 31, 2026.

俄勒岡州湖奧斯維戈 --（Newsfile Corp. -2026年5月18日）- Functional Brands Inc.（納斯達克：MEHA），一家領先的健康與性能產品創新公司，今天公佈了截至2026年3月31日的第一季度財務業績。

First Quarter 2026 Financial Highlights

2026 年第一季度財務亮點

Revenue grew to $1.65 million, up 3.5% from $1.59 million in the prior year period, reflecting continued momentum across the Company's brand portfolio.
Gross profit increased to $0.96 million from $0.87 million in the prior year period and gross margin increased 390 basis points to 58.4%, driven by continued focus on higher margin channels.
Operating loss increased to $0.68 million from $0.03 million in the prior year period, largely reflecting expenses related to becoming a public company.
Net loss of $7.0 million reflected a $6.3 million of non-cash GAAP charge on equity exchange.

收入增長至 165 萬美元，比去年同期的 159 萬美元增長 3.5%，反映出公司品牌組合的持續勢頭。
毛利潤從去年同期的 87 萬美元增加至 96 萬美元，毛利率提高 390 個基點至 58.4%，主要得益於對高毛利渠道的持續關注。
運營虧損從去年同期的 3 萬美元增加至 68 萬美元，主要反映出成為上市公司的相關費用。
淨虧損為 700 萬美元，反映出 630 萬美元的非現金 GAAP 股權交換費用。

Strategic Highlights

戰略亮點

Continued expansion of Kirkman® distribution across eCommerce, retail, and international channels.
Tru2u.health platform gaining traction with growing registered user base.
P2i™ Prenatal line achieving broader practitioner and retail placement following iHerb listing.
Strategic AI partnership with partnrup.ai driving qualified traffic acquisition for Tru2u.health.
Entered into a binding letter of intent regarding the acquisition of intellectual property and related blockchain-based assets.
Completed a capital structure simplification.

在電子商務、零售和國際渠道繼續擴大 Kirkman®的分銷。
Tru2u.health 平台用户註冊數量不斷增長，獲得了越來越多的關注。
P2i™孕期系列在 iHerb 上市後獲得了更廣泛的專業人士和零售商的認可。
與 partnrup.ai 建立戰略 AI 合作伙伴關係，為 Tru2u.health 驅動合格流量獲取。
簽署了一份關於收購知識產權及相關區塊鏈資產的具有約束力的意向書。
完成了資本結構的簡化。

"Our recent results reflect important strategic and operational progress, including revenue growth, a 390 basis point expansion of gross margin, and the completion of a simplification of our capital structure," said Eric Gripentrog, CEO of Functional Brands Inc. "Over the past several months, we've executed a series of key initiatives that mark a pivotal period in the Company's evolution and establish a strong foundation for sustainable, profitable growth."

“我們最近的業績反映了重要的戰略和運營進展，包括收入增長、毛利率擴展 390 個基點，以及資本結構簡化的完成，” Functional Brands Inc.首席執行官 Eric Gripentrog 表示。“在過去幾個月中，我們執行了一系列關鍵舉措，標誌着公司發展的關鍵時期，併為可持續、盈利的增長奠定了堅實基礎。”

Financial Results for the Quarter Ended March 31, 2026:

截至2026年3月31日的季度財務業績：

Revenue

收入

Net revenue for the three months ended March 31, 2026 was $1,645,524 compared to $1,590,256 for the three months ended March 31, 2025 representing an increase of approximately 3.5%. This increase of $55,268 in net revenue was primarily due to the increase in the demand from our direct-to-consumer sales channel.

截至2026年3月31日的三個月淨收入為 1,645,524 美元，而截至2025年3月31日的三個月淨收入為 1,590,256 美元，增長約 3.5%。這 55,268 美元的淨收入增長主要是由於我們直接面向消費者銷售渠道需求的增加。

Gross profit

毛利潤

Gross profit for the three months ended March 31, 2026 was $961,133 compared to 866,764 representing an increase of 11%. This increase of $94,369 was primarily due to the increase in demand from direct-to-consumer sales channel and operational efficiencies. Gross profit margin increased 390 basis points to 58.4%, driven by continued focus on higher margin channels.

截至2026年3月31日的三個月毛利潤為 961,133 美元，而 866,764 美元的毛利潤增長了 11%。這 94,369 美元的增長主要是由於直接面向消費者銷售渠道需求的增加和運營效率的提高。毛利潤率提高 390 個基點至 58.4%，得益於對高毛利渠道的持續關注。

Sales and marketing expenses

銷售和營銷費用

Sales and marketing expenses for the three months ended March 31, 2026, was $263,707 compared to $178,630 for the three months ended March 31, 2025, representing an increase of approximately 48%. This increase of $85,077 was primarily due to the increase in amazon referral fees and commissions moving from a wholesaler model to a Direct Seller's Central model.

截至2026年3月31日的三個月銷售和營銷費用為 263,707 美元，而截至2025年3月31日的三個月銷售和營銷費用為 178,630 美元，增長約 48%。這 85,077 美元的增長主要是由於亞馬遜推薦費用和佣金的增加，以及從批發商模式轉向直接銷售中心模式。

General and administrative expenses

一般和行政費用

General and administrative expenses for the three months ended March 31, 2026 was $1,380,231, compared to $720,234 for the three months ended March 31, 2025, representing an increase of approximately 92%. This increase of $659,997 was primarily attributable to an increase professional fees and payroll.

截至2026年3月31日的三個月一般和行政費用為 1,380,231 美元，而截至2025年3月31日的三個月一般和行政費用為 720,234 美元，增長約 92%。這 659,997 美元的增長主要歸因於專業費用和工資的增加。

Other income / (expenses)

其他收入 /（費用）

Other income /expense for the three months ended March 31, 2026 was a negative $6,307,984 compared to a negative of $94,682 for the three months ended March 31, 2025. This increase of $6,213,302 was primarily due to the loss on issuance of preferred stock of $6,310,464, a reduction in interest expense of $69,290, and a change of fair value of derivative liability of $25,374.

截至2026年3月31日的三個月其他收入/費用為負 6307984 美元，而截至2025年3月31日的三個月其他收入/費用為負 94682 美元。這 6213302 美元的增加主要是由於優先股發行損失 6310464 美元、利息費用減少 69290 美元，以及衍生負債公允價值變動 25374 美元。

About Functional Brands Inc.

關於 Functional Brands Inc.

Functional Brands Inc. (NASDAQ: MEHA) is a leading innovator in wellness and performance products dedicated to Making Everyone Healthy Again™. The Company's portfolio includes Kirkman®, one of the most trusted names in nutritional supplements for over 75 years with products available in more than 35 countries; P2i™ by Kirkman® Prenatal Multivitamin & Multimineral, the first prenatal supplement to align with FIGO standards and comply with California SB 646; and Tru2u.health, a consumer-facing telehealth and wellness platform. Functional Brands operates an FDA-registered, cGMP-compliant manufacturing facility in Oregon.

Functional Brands Inc.（納斯達克：MEHA）是一家領先的健康與性能產品創新公司，致力於讓每個人再次健康。公司的產品組合包括 Kirkman®，這是一個在營養補充品領域擁有超過 75 年曆史的最受信任的品牌之一，其產品在 35 個國家銷售；P2i™ by Kirkman®孕期多種維生素和礦物質，這是第一個符合 FIGO 標準並遵循加州 SB 646 的孕期補充品；以及 Tru2u.health，一個面向消費者的遠程醫療和健康平台。Functional Brands 在俄勒岡州運營一家 FDA 註冊的 cGMP 合規制造設施。

For more information, visit www.functionalbrandsinc.com and www.kirkmangroup.com, and www.Tru2u.health.

欲瞭解更多信息，請訪問 www.functionalbrandsinc.com 和 www.kirkmangroup.com，以及 www.Tru2u.health。

Cautionary Note Regarding Forward-Looking Statements

關於前瞻性聲明的警示説明

This news release and statements of Functional Brands' management in connection with this news release or related events contain or may contain "forward-looking statements" within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and the Private Securities Litigation Reform Act of 1995. In this context, forward-looking statements mean statements (including statements related to the closing, and the anticipated benefits to the Company, of the private placement described herein) related to future events, which may impact our expected future business and financial performance, and often contain words such as "expects," "anticipates," "intends," "plans," "believes," "potential," "will," "should," "could," "would," "optimistic" or "may" and other words of similar meaning. These forward-looking statements are based on information available to us as of the date of this news release and represent management's current views and assumptions. Forward-looking statements are not guarantees of future performance, events or results and involve significant known and unknown risks, uncertainties and other factors which may be beyond our control.

本新聞稿及 Functional Brands 管理層與本新聞稿或相關事件相關的聲明包含或可能包含根據 1934 年證券交易法第 21E 條及 1995 年私人證券訴訟改革法的定義的 “前瞻性聲明”。在此背景下，前瞻性聲明是指與未來事件相關的聲明（包括與此處描述的私募配售的完成及對公司的預期利益相關的聲明），這些事件可能影響我們預期的未來業務和財務表現，並且通常包含 “預計”、“預期”、“打算”、“計劃”、“相信”、“潛在”、“將”、“應該”、“可能”、“會”、“樂觀” 或 “可能” 等詞彙及其他類似含義的詞彙。這些前瞻性聲明基於截至本新聞稿日期可獲得的信息，並代表管理層當前的觀點和假設。前瞻性聲明並不保證未來的表現、事件或結果，並涉及重大已知和未知的風險、不確定性及其他可能超出我們控制的因素。

Important factors that may cause actual results and outcomes to differ materially from those contained in such forward-looking statements include, without limitation, the ability of the parties to negotiate final terms of a definitive acquisition agreement, the closing of the contemplated asset purchase agreement, including expected conditions to closing which are anticipated to include regulatory approvals, valuations, and future shareholder approvals; the occurrence of any event, change or other circumstances that could give rise to the right of one or both of the Company or BullionFX (collectively, the "LOI Parties") to terminate the LOI agreement; the effect of such termination; the outcome of any legal proceedings that may be instituted against LOI Parties or their respective directors or officers; the ability to obtain regulatory and other approvals and meet other closing conditions for the asset acquisition on a timely basis or at all, including the risk that any regulatory and other approvals required may not obtained on a timely basis or at all, or are obtained subject to conditions that are not anticipated or that could adversely affect the combined company or the expected benefits of the transaction; the ability to obtain any necessary approval by the Company's stockholders on the expected schedule of the transactions contemplated by the LOI; difficulties and delays in integrating BullionFX's assets in the Company; prevailing economic, market, regulatory or business conditions, or changes in such conditions, negatively affecting the parties; potential adverse reactions or changes to business relationships resulting from the announcement of the LOI and future expected acquisition; uncertainty as to the long-term value of the common stock of the Company following the acquisition; the significant dilution to the Company's stockholder in connection with the acquisition; the continued availability of capital and financing following the potential acquisition transaction; the business, economic and political conditions in the markets in which the LOI Parties operate; and the fact that the Company's reported earnings and financial position may be adversely affected by tax and other factors.

可能導致實際結果和結果與此類前瞻性聲明中所包含的內容存在重大差異的重要因素包括但不限於：各方談判最終條款的能力，擬議資產購買協議的完成，包括預計的關閉條件，這些條件預計將包括監管批准、估值和未來股東批准；任何事件、變化或其他情況的發生，可能使公司或 BullionFX（統稱為 “LOI 各方”）有權終止 LOI 協議；此類終止的影響；可能對 LOI 各方或其各自的董事或高管提起的任何法律程序的結果；及時或根本無法獲得監管和其他批准並滿足資產收購的其他關閉條件的能力，包括任何所需的監管和其他批准可能無法及時獲得或根本無法獲得，或在不被預期的條件下獲得，可能對合並公司或交易的預期利益產生不利影響；在 LOI 所設想的交易的預期時間表上獲得公司股東的任何必要批准的能力；將 BullionFX 的資產整合到公司中的困難和延誤；影響各方的經濟、市場、監管或商業條件的變化；由於 LOI 的公告和未來預期收購而導致的潛在不利反應或商業關係的變化；收購後公司普通股的長期價值的不確定性；與收購相關的對公司股東的重大稀釋；潛在收購交易後資本和融資的持續可用性；LOI 各方所經營市場的商業、經濟和政治條件；以及公司報告的收益和財務狀況可能受到税收和其他因素的不利影響。

Readers are cautioned not to place undue reliance on these forward-looking statements, which apply only as of the date of this news release. Potential investors should review Functional Brands' Registration Statement filed with the SEC on Form S-1 on October 16, 2025 and the Company's Annual Report on Form 10-K filed with the SEC on March 27, 2026 for more complete information, including the risk factors that may affect future results, which are available for review at www.sec.gov. Accordingly, forward-looking statements should not be relied upon as a predictor of actual results. We do not undertake to update our forward-looking statements to reflect events or circumstances that may arise after the date of this news release, except as required by law.

讀者被提醒不要過度依賴這些前瞻性聲明，這些聲明僅適用於本新聞稿發佈之日。潛在投資者應查看 Functional Brands 於2025年10月16日向 SEC 提交的 S-1 表格註冊聲明以及公司於2026年3月27日向 SEC 提交的 10-K 表格年度報告，以獲取更完整的信息，包括可能影響未來結果的風險因素，這些文件可在 www.sec.gov 上查閲。因此，前瞻性聲明不應被視為實際結果的預測。除法律要求外，我們不承諾更新我們的前瞻性聲明，以反映本新聞稿發佈日期後可能出現的事件或情況。

FUNCTIONAL BRANDS INC.

CONSOLIDATED BALANCE SHEETS (UNAUDITED)

合併資產負債表（未經審計）

(In U.S. dollars, except share data or otherwise noted)

（以美元計，除非另有説明）


	March 31,		December 31,
	2026		2025
Assets
Current assets:
Cash	$	1,077,967		$	2,726,696
Accounts receivable, net		372,712			518,474
Inventories, net		1,591,548			1,549,511
Prepaid expenses and other current assets		355,096			392,999
Total current assets		3,397,323			5,187,680
Noncurrent assets:
Property and equipment, net		32,797			37,379
Right-of-use assets, net		1,579,814			1,667,693
Intangible assets, net		1,385,879			1,397,411
Goodwill		818,139			818,139
Total non-current assets		3,816,629			3,920,622
Total assets	$	7,213,952		$	9,108,302

Liabilities and stockholders' equity / (deficit)
Current liabilities:
Accounts payable and accrued liabilities	$	1,645,659		$	1,554,243
Line of credit		-			8,109
SBA loan, current		3,614			3,595
Lease liabilities, current		375,479			371,272
Other current liabilities		30,678			41,828
Derivative liabilities, current		-			3,306,745
Liability with conditional timing		450,000			-
Loans payable (related party), current		64,527			61,642
Loans payable		267,883			402,650
Total current liabilities		2,837,840			5,750,084
Non-current liabilities:
Lease liabilities, net of current		1,340,313			1,435,505
SBA loan, net of current		135,957			136,873
Convertible note		837,800			-
Derivative liabilities, noncurrent		313,392			-
Preferred shares liabilities		6,032,160			-
Loan payable (related party), net of current		227,254			244,509
Total non-current liabilities		8,886,876			1,816,887

Total liabilities		11,724,716			7,566,971

Stockholders' equity / (deficit)
Series A Preferred stock, par value $0.001 stated value $100, 100,000 shares authorized in 2026 and 2025; 0 and 87,445 shares issued and outstanding, respectively		-			87
Series B Preferred stock, par value $0.001 stated value $100, 80,000 authorized in 2026 and 2025; 2,400 and 28,475 shares issued and outstanding, respectively		2			28
Series C Preferred stock, par value $0.001 stated value $1,000, 6,100 and 0 authorized in 2026 and 2025; 6,032 and 0 shares issued and outstanding, respectively		-			-
Common stock, $0.00001 par value, 220,000,000 shares authorized, 21,354,686 and 18,704,649 shares outstanding, and 5,190,171 and 0 shares to be issued respectively.		267			187
Additional paid-in capital		9,538,131			8,522,354
Accumulated deficit		(14,049,164	)		(6,981,325	)
Total stockholders' equity / (deficit)		(4,510,764	)		1,541,331
Total liabilities and stockholders' equity / (deficit)	$	7,213,952		$	9,108,302


	2026年3月31日		2025年12月31日
資產
流動資產：
現金	$	1,077,967		$	2,726,696
應收賬款，淨額		372,712			518,474
存貨，淨額		1,591,548			1,549,511
預付費用及其他流動資產		355,096			392,999
流動資產總計		3,397,323			5,187,680
非流動資產：
不動產及設備，淨額		32,797			37,379
使用權資產，淨額		1,579,814			1,667,693
無形資產，淨額		1,385,879			1,397,411
商譽		818,139			818,139
非流動資產總計		3,816,629			3,920,622
資產總計	$	7,213,952		$	9,108,302

負債及股東權益 /（赤字）
流動負債：
應付賬款及應計負債	$	1,645,659		$	1,554,243
信貸額度		-			8,109
SBA 貸款，流動		3,614			3,595
租賃負債，流動		375,479			371,272
其他流動負債		30,678			41,828
衍生負債，流動		-			3,306,745
有條件時間負債		450,000			-
應付貸款（關聯方），流動		64,527			61,642
應付貸款		267,883			402,650
流動負債總計		2,837,840			5,750,084
非流動負債：
租賃負債，淨流動		1,340,313			1,435,505
SBA 貸款，淨流動		135,957			136,873
可轉換票據		837,800			-
衍生負債，非流動		313,392			-
優先股負債		6,032,160			-
應付貸款（關聯方），淨流動		227,254			244,509
非流動負債總計		8,886,876			1,816,887

負債總計		11,724,716			7,566,971

股東權益 /（赤字）
A 系列優先股，面值$0.001，聲明價值$100，2026 年和 2025 年授權 100,000 股；分別發行和流通 0 股和 87,445 股		-			87
B 系列優先股，面值$0.001，聲明價值$100，2026 年和 2025 年授權 80,000 股；分別發行和流通 2,400 股和 28,475 股		2			28
C 系列優先股，面值$0.001，聲明價值$1,000，2026 年和 2025 年授權 6,100 股和 0 股；分別發行和流通 6,032 股和 0 股		-			-
普通股，面值$0.00001，授權 220,000,000 股，流通 21,354,686 股和 18,704,649 股，分別待發行 5,190,171 股和 0 股。		267			187
額外實收資本		9,538,131			8,522,354
累計赤字		(14,049,164	)		(6,981,325	)
股東權益總計 /（赤字）		(4,510,764	)		1,541,331
負債及股東權益總計 /（赤字）	$	7,213,952		$	9,108,302

The accompanying notes are an integral part of these unaudited consolidated financial statements.

附帶的註釋是這些未經審計的合併財務報表的組成部分。

FUNCTIONAL BRANDS INC.

功能品牌公司

CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)

合併損益表（未經審計）

(In U.S. dollars, except share data or otherwise noted)

（以美元計，除非另有説明）


	Three Months Ended		Three Months Ended
	March 31,		March 31,
	2026		2025
Revenue, net of returns		1,645,524			1,590,256
Cost of goods sold		684,391			723,492
Gross profit		961,133			866,764
Operating expenses
Sales and marketing		263,707			178,630
General and administrative		1,380,231			720,234
Total operating expenses		1,643,938			898,864
Operating loss		(682,805	)		(32,100	)
Other income / (expense)
Interest income		2,910			299
Other income		-			113
Interest expense		(25,804	)		(95,094	)
Change in fair value of derivative liabilities		25,374			-
Loss on issuance of preferred stock		(6,310,464	)		-
Total other income / (expense)		(6,307,984	)		(94,682	)
Net loss	$	(6,990,789	)	$	(126,782	)
Net loss per share of common stock attributable to common stockholders		-
Basic	$	(0.36	)	$	(0.02	)
Diluted	$	(0.36	)	$	(0.02	)
Weighted average shares used in computing net loss per share of common stock
Basic		19,594,102			6,917,226
Diluted		19,594,102			6,917,226


	截至三個月
結束		截至三個月
結束
	2026年3月31日		2025年3月31日
收入，扣除退貨		1,645,524			1,590,256
銷售成本		684,391			723,492
毛利潤		961,133			866,764
營業費用
銷售和市場營銷		263,707			178,630
一般和行政		1,380,231			720,234
營業費用總計		1,643,938			898,864
營業虧損		(682,805	)		(32,100	)
其他收入 /（費用）
利息收入		2,910			299
其他收入		-			113
利息費用		(25,804	)		(95,094	)
衍生負債公允價值變動		25,374			-
優先股發行損失		(6,310,464	)		-
其他收入 /（費用）總計		(6,307,984	)		(94,682	)
淨虧損	$	(6,990,789	)	$	(126,782	)
歸屬於普通股股東的每股普通股淨虧損		-
基本	$	(0.36	)	$	(0.02	)
稀釋	$	(0.36	)	$	(0.02	)
計算普通股每股淨虧損所用的加權平均股數
基本		19,594,102			6,917,226
稀釋		19,594,102			6,917,226

The accompanying notes are an integral part of these unaudited consolidated financial statements.

附帶的註釋是這些未經審計的合併財務報表的組成部分。

FUNCTIONAL BRANDS INC.

功能品牌公司

CONSOLIDATED STATEMENTS OF CASH FLOW (UNAUDITED)

合併現金流量表（未經審計）

(In U.S. dollars, except share data or otherwise noted)

（以美元計，除非另有説明）


	Three Months Ended		Three Months Ended
	March 31,		March 31,
	2026		2025
Cash flows from operating activities:
Net loss	$	(6,990,789	)	$	(126,782	)
Reconcile net loss to cash provided by operating activities
Allowance for doubtful accounts receivable		-			(1,968	)
Allowance for inventory obsolescence		-			18,464
Depreciation of property and equipment		4,582			6,225
Amortization of right-of-use assets		87,879			80,355
Amortization of intangible assets		11,532			11,532
Stock-based compensation		123,288			252,905
Financing expense on warrants		-			23,138
Change in fair value of derivative liabilities		(25,374	)		-
Loss on issuance of preferred stock		6,310,464			-
Dividends		(77,050	)		-
Changes in operating assets and liabilities:
Accounts receivable		145,762			5,841
Inventories		(42,037	)		(111,142	)
Prepaid expenses and other current assets		37,903			17,029
Accounts payable and accrued liabilities		91,416			86,959
Other current liabilities		(11,150	)		(7,065	)
Lease liabilities		(90,985	)		(79,498	)
Net cash provided by (used in) operating activities		(424,559	)		175,993

Cash flows from investing activities:
Net cash used in investing activities:		-			-

Cash flows from financing activities:
Deferred offering costs		-			(127,775	)
Payments for payable for acquisition		-			(44,999	)
Repayment of liability conditional timing		(450,000	)		-
Repayment of loans		(149,137	)		(1,685	)
Buyback of preferred stock		(616,027	)		-
Proceeds from line of credit		-			48,947
Line of credit repayment		(8,109	)		(47,598	)
SBA loan repayment		(897	)		(894	)
Net cash used in financing activities		(1,224,170	)		(174,004	)

Increase (decrease) in cash		(1,648,729	)		1,989

Cash beginning of period		2,726,696			211,642

Cash, end of period	$	1,077,967		$	213,631

Supplemental disclosures of cash flow information
Cash paid for interest	$	19,469		$	71,980
Non-cash investing and financing activities
Declaration of preferred stock dividend recorded as an increase in accrued liabilities		77,050			-

Extinguishment of Series A&B preferred shares	$	(97	)
Derecognition of derivative liabilities upon extinguishment of Series A&B preferred shares	$	(3,027,287	)
Issuance of Series C preferred shares	$	(6,032,160	)
Recognition of Series C convertible notes	$	(837,000	)
Recognition of derivative liabilities upon issuance of Series C preferred shares & convertible notes	$	(529,854	)


	三個月截至		三個月截至
	2026年3月31日		2025年3月31日
現金流來自經營活動：
淨虧損	$	(6,990,789	)	$	(126,782	)
將淨虧損調整為經營活動提供的現金
應收賬款壞賬準備		-			(1,968	)
存貨減值準備		-			18,464
固定資產折舊		4,582			6,225
使用權資產攤銷		87,879			80,355
無形資產攤銷		11,532			11,532
基於股票的補償		123,288			252,905
權證融資費用		-			23,138
衍生負債公允價值變動		(25,374	)		-
優先股發行損失		6,310,464			-
股息		(77,050	)		-
經營資產和負債的變動：
應收賬款		145,762			5,841
存貨		(42,037	)		(111,142	)
預付費用及其他流動資產		37,903			17,029
應付賬款及應計負債		91,416			86,959
其他流動負債		(11,150	)		(7,065	)
租賃負債		(90,985	)		(79,498	)
經營活動提供的（使用的）淨現金		(424,559	)		175,993

現金流來自投資活動：
投資活動使用的淨現金：		-			-

現金流來自融資活動：
延期發行費用		-			(127,775	)
收購應付款項		-			(44,999	)
有條件償還的負債		(450,000	)		-
貸款償還		(149,137	)		(1,685	)
優先股回購		(616,027	)		-
信貸額度收入		-			48,947
信貸額度償還		(8,109	)		(47,598	)
SBA 貸款償還		(897	)		(894	)
融資活動使用的淨現金		(1,224,170	)		(174,004	)

現金增加（減少）		(1,648,729	)		1,989

期初現金		2,726,696			211,642

期末現金	$	1,077,967		$	213,631

現金流信息的補充披露
支付的利息	$	19,469		$	71,980
非現金投資和融資活動
宣佈的優先股股息記錄為應計負債的增加		77,050			-

清償 A&B 系列優先股	$	(97	)
清償 A&B 系列優先股時衍生負債的註銷	$	(3,027,287	)
發行 C 系列優先股	$	(6,032,160	)
確認 C 系列可轉換票據	$	(837,000	)
發行 C 系列優先股和可轉換票據時確認的衍生負債	$	(529,854	)

The accompanying notes are an integral part of these unaudited consolidated financial statements.

附帶的註釋是這些未經審計的合併財務報表的重要組成部分。

To view the source version of this press release, please visit https://www.newsfilecorp.com/release/297768

要查看本新聞稿的源版本，請訪問 https://www.newsfilecorp.com/release/297768

Functional Brands 公佈 2026 年第一季度財務業績 | MEHA 股票新聞